Carto Technology
Elva Stuller
About Biosense Webster
Biosense Webster, part of Johnson & Johnson MedTech, leads in cardiac arrhythmia diagnosis and treatment worldwide. We are dedicated to advancing electrophysiology and interventional cardiology tools and solutions for improved patient care. Learn more at biosensewebster.com and connect on LinkedIn and X, formerly Twitter.
About Johnson & Johnson MedTechix
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized. For more information, visit thenext.jnjmedtech.com.
iiiWhen using Smart Index mapping. Optimized maps are referred to as overall higher Smart Index score indicating the quality of the map. 25 out of 25 cases used to evaluate the performance the Enhanced ConfiDENSE algorithm passed the acceptance criteria.
1Di Biase L, Zou F, Lin AN, et al. Feasibility of Three-Dimensional Artificial Intelligence Algorithm Integration with Intracardiac Echocardiography for Left Atrial Imaging During Atrial Fibrillation Catheter Ablation. Europace. 2023 Aug 2;25(9):euad211.
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. Cookie Policy.
You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact us with any questions or search this site for more information.
Arrhythmias occur when the electrical impulses that coordinate the heartbeat are abnormally fast, irregular, or come from places other than the normal conduction system of the heart. This causes you to suffer from tachycardia (heartbeats too fast), bradycardia (heartbeats too slow), or irregular heartbeats.
80% of cardiac arrhythmias can be treated by catheter ablation, thus eliminating the need for medication. This procedure allows very small scars to be created in the areas of the heart that are involved in heart rhythm problems. Although many of these arrhythmias can be treated with the conventional system, there is a group of complex arrhythmias that require special mapping called CARTO, which consists of three-dimensional (3D) electro-anatomical mapping.
The CARTO electro-anatomical mapping equipment uses catheters that have a location sensor to acquire the electrogram automatically and simultaneously in each position, as well as its coordinates in each location, thus creating a three-dimensional electro-anatomical map of the chamber where the arrhythmia originates, providing real-time information that is highly relevant to ablation.
It is important to note that these procedures are performed by renowned electrophysiologists, that is, cardiologists highly specialized in electrophysiology, who identify and treat arrhythmias through high-resolution studies such as CARTO and interventional procedures such as cardiac ablation. All the electrophysiologists that belong to the Medical Corps (Staff) of the ABC Medical Center have the certification and validity of the Mexican Council of Cardiology, which ensures their professional excellence.
The Intervention Rooms at ABC Medical Center are among the most modern in Mexico, they have large spaces to work, they are fully equipped, and have the most modern technology for these procedures, including CARTO.
What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, malaise, and swollen lymph nodes.
How long will it take for me to be protected and what does it protect me from?
After 14 days of having the complete scheme (after the administration of the 2nd dose), the protection period is still under study. It protects us from serious COVID-19 or requiring hospitalization.
What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, muscle pain, chills, joint pain, fever, nausea, and swollen lymph nodes in the arm in which you received the injection.
How long will it take for me to be protected and what does it protect me from?
After 28 days of having the complete scheme (the last dose applied), the protection period is still under study. It protects us from 85% serious COVID-19 or requiring hospitalization.
What are the possible side effects of the vaccine?
Pain where the injection was given, fatigue, headache, myalgia, arthralgia, and fever, which were mild to moderate in intensity and disappeared within 48 hours of vaccination.
Our hybrid surgical suite is a surgical operating room that features advanced imaging techniques. This combination of capabilities lets our interventional cardiologists and cardiovascular surgeons perform multiple procedures at the same time. All structural heart, endoscopic and peripheral procedures are performed in our hybrid surgical suite.
The left ventricular assist device, LVAD for short, is a medical device that helps to pump blood into the body from the left ventricle of the heart. It is implanted into the heart through your chest during a surgical procedure. A drive line connects the internally implanted pump (LVAD) to an external controller and power source.
The Carto 3 System allows our team to make a 3D digital map of the left atrium and pulmonary arteries. This technology is used with either the RF ablation or cryo ablation as a treatment for atrial fibrillation.
Biosense Webster president Jasmina Brooks said: We are pleased to announce this new version of our Carto 3 System, which reflects our continued focus on harnessing the latest science and technology to advance tools for electrophysiologists to treat cardiac arrhythmias.
Montefiore-Einstein Health System electrophysiology system director and Albert Einstein College of Medicine cardiology professor of medicine Luigi Di Biase said: Carto 3 System Version 8 incorporates a novel component, the Cartosound FAM Module, which, for the first time, utilises artificial intelligence to reconstruct the left atrial anatomy, streamlining the process for electrophysiologists.
NEW YORK , Dec. 14, 2021 /PRNewswire/ -- CARTO, the cloud native spatial analysis platform, today announces the closure of a $61 million Series C round led by New York-based global venture capital and private equity firm Insight Partners, with participation from the EIC Fund, as well as existing investors Accel, Salesforce Ventures, Hearst Ventures, Earlybird and Kibo.
Spatial analytics enables organizations to not only understand where things happen, but why they happen. Traditionally, this type of analytics was carried out by specialized analysts in the GIS industry, but with CARTO's location intelligence platform, access to this technology is now democratized by enabling spatial analysis on cloud data warehouses using structured query language (SQL). This latest funding will be used to further accelerate these cloud integrations, enabling the New York-based company to continue its rapid growth in verticals such as consumer packaged goods (CPG), retail, logistics, telecoms and beyond.
Trusted by market leaders such as JLL, Mastercard and T-Mobile, CARTO has long led the charge in enabling analysts to use SQL for spatial use cases. Now, with many organizations moving to the cloud, CARTO enables an end-to-end analytics workflow on location data, directly on top of the major cloud data warehouses. With support for Google BigQuery, Snowflake, Amazon Redshift, Databricks and PostgreSQL systems, CARTO provides a full cloud-native approach to spatial analytics versus legacy GIS systems. This results in a more scalable and cost-effective solution to working with spatial data, and adds an unrivalled level of interoperability, through Spatial SQL.
"The rise of the data warehouse has allowed organizations to unify and connect all their data in a single location, and geospatial data is no exception," said Luis Sanz, CEO of CARTO. "Now, thanks to our cloud native offering, they can also perform spatial analytics on top of them. Our Spatial Extension runs on top of all the major data warehouses and takes full advantage of all their benefits, giving our users a complete suite for geospatial analysis that is highly performant, scalable and secure. And because Spatial SQL uses all the same elements and structure of regular SQL, it is compatible with all modern analytics stacks. Whether it is site selection for brick & mortar, route optimization in logistics or customer segmentation in CPG - more and more businesses want to understand not only where things are happening, but also why they are happening there - and that's what CARTO enables."
93ddb68554